TREA

97978677 - AVERITAS PHARMA

Follow

Information

  • Trademark
  • 97978677
  • Serial Number
    97978677
  • Registration Number
    7525040
  • Filing Date
    April 26, 2022
    2 years ago
  • Registration Date
    October 01, 2024
    3 months ago
  • Transaction Date
    October 01, 2024
    3 months ago
  • Status Date
    October 01, 2024
    3 months ago
  • Published for Opposition Date
    March 28, 2023
    a year ago
  • Location Date
    August 28, 2024
    4 months ago
  • First Use Anywhere Date
    November 27, 2018
    6 years ago
  • First Use In Commerce Date
    March 29, 2019
    5 years ago
  • Status Code
    700
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    LEE, CATHERINE
  • Attorney Docket Number
    1101804-0002
    Attorney Name
    Paul C. Llewellyn
    Law Office Assigned Location Code
    M10
  • Owners
Information
Mark Drawing Code
4
Mark Identification
AVERITAS PHARMA
Case File Statements
  • GS0051: Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, and neurological diseases and disorders
  • DS0000: "PHARMA"
Case File Event Statements
  • 5/2/2022 - 2 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 2/21/2023 - a year ago
    5 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 2/21/2023 - a year ago
    8 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 3/28/2023 - a year ago
    10 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 3/28/2023 - a year ago
    11 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 4/29/2022 - 2 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP
  • 2/21/2023 - a year ago
    4 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 2/21/2023 - a year ago
    7 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 2/14/2023 - a year ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 2/21/2023 - a year ago
    6 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 3/8/2023 - a year ago
    9 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 5/23/2023 - a year ago
    12 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM
  • 11/20/2023 - a year ago
    15 - SOU EXTENSION 1 GRANTED Type: EX1G
  • 11/20/2023 - a year ago
    14 - SOU EXTENSION 1 FILED Type: EXT1
  • 11/20/2023 - a year ago
    13 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 5/2/2024 - 8 months ago
    28 - DIVISIONAL REQUEST RECEIVED Type: DRRR
  • 5/2/2024 - 8 months ago
    19 - SOU EXTENSION 2 GRANTED Type: EX2G
  • 5/2/2024 - 8 months ago
    18 - SOU EXTENSION 2 FILED Type: EXT2
  • 5/2/2024 - 8 months ago
    17 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 11/22/2023 - a year ago
    16 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 5/2/2024 - 8 months ago
    30 - USE AMENDMENT FILED Type: IUAF
  • 5/2/2024 - 8 months ago
    21 - TEAS STATEMENT OF USE RECEIVED Type: EISU
  • 5/3/2024 - 8 months ago
    22 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 6/10/2024 - 6 months ago
    23 - CASE ASSIGNED TO INTENT TO USE PARALEGAL Type: AITU
  • 6/11/2024 - 6 months ago
    24 - ITU OFFICE ACTION ISSUED FOR DIVISIONAL REQUEST Type: INCD
  • 8/7/2024 - 4 months ago
    26 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 8/13/2024 - 4 months ago
    29 - DIVISIONAL PROCESSING COMPLETE Type: DPCC
  • 8/13/2024 - 4 months ago
    31 - STATEMENT OF USE PROCESSING COMPLETE Type: SUPC
  • 5/2/2024 - 8 months ago
    20 - TEAS REQUEST TO DIVIDE RECEIVED Type: ERTD
  • 8/7/2024 - 4 months ago
    27 - RESPONSE TO ITU OFFICE ACTION ENTERED Type: IROA
  • 8/7/2024 - 4 months ago
    25 - ITU OFFICE ACTION ISSUED FOR DIVISIONAL REQUEST Type: INCD
  • 8/28/2024 - 4 months ago
    32 - ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Type: CNPR
  • 8/28/2024 - 4 months ago
    33 - NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Type: SUNA
  • 10/1/2024 - 3 months ago
    34 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 10/1/2024 - 3 months ago
    35 - NOTICE OF REGISTRATION CONFIRMATION EMAILED Type: NRCC